Literature DB >> 11929642

Case-control studies on venous thromboembolism: bias due to design? A methodological study on venous thromboembolism and steroid hormone use.

Lothar A J Heinemann1, Michael A Lewis, Anita Assmann, Christine Thiel.   

Abstract

This study addressed methodological issues of epidemiologic studies on venous thromboembolism (VTE) to show how design decisions can affect the results. It examines the influence of a restricting to hospitalized and to "idiopathic" cases of VTE in case-control studies on VTE risk and oral contraceptive (OC) use and thereby the bias potential. The diagnostic processes and OC exposures of 1068 suspected cases of VTE were followed in 21 German centers from 1994 to 1999 and evaluated compared to population and hospital controls. Of 606 confirmed cases, 385 (65.5%) were hospitalized, 168 (27.7%) were "idiopathic." Comparing users versus nonusers of OCs, the odds ratio (OR) for VTE risk for all cases and controls was 3.38 and 5.44 for "idiopathic" VTE. For hospital cases and controls, the OR was 3.72 and 9.1 for "idiopathic" VTE. The risk ratio for third- vs. second-generation OCs was increased in the hospital base but not in the population base. It was concluded that restriction to hospitalized events and exclusions of certain cases overestimate the VTE risk of OCs. An evidence-based consensus on methodological standards and definitions in case-control studies on VTE and steroid hormone use is required.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11929642     DOI: 10.1016/s0010-7824(01)00309-2

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  12 in total

Review 1.  Oral contraceptives and venous thromboembolism: a systematic review and meta-analysis.

Authors:  Lamberto Manzoli; Corrado De Vito; Carolina Marzuillo; Antonio Boccia; Paolo Villari
Journal:  Drug Saf       Date:  2012-03-01       Impact factor: 5.606

2.  Using the Prediction Model Risk of Bias Assessment Tool (PROBAST) to Evaluate Melanoma Prediction Studies.

Authors:  Isabelle Kaiser; Sonja Mathes; Annette B Pfahlberg; Wolfgang Uter; Carola Berking; Markus V Heppt; Theresa Steeb; Katharina Diehl; Olaf Gefeller
Journal:  Cancers (Basel)       Date:  2022-06-20       Impact factor: 6.575

Review 3.  Safety of a new oral contraceptive containing drospirenone.

Authors:  Lothar A J Heinemann; Jürgen Dinger
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

4.  Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?

Authors:  W Miehsler; W Reinisch; E Valic; W Osterode; W Tillinger; T Feichtenschlager; J Grisar; K Machold; S Scholz; H Vogelsang; G Novacek
Journal:  Gut       Date:  2004-04       Impact factor: 23.059

5.  Comparison of incidence/risk of venous thromboembolism (VTE) among selected clinical and hereditary risk markers: a community-based cohort study.

Authors:  Michael Spannagl; Lothar A J Heinemann; Thai Dominh; Anita Assmann; Wolfgang Schramm; Rolf Schürmann
Journal:  Thromb J       Date:  2005-07-20

6.  Selection bias: neighbourhood controls and controls selected from those presenting to a Health Unit in a case control study of efficacy of BCG revaccination.

Authors:  Odimariles M S Dantas; Ricardo A A Ximenes; Maria de Fatima P M de Albuquerque; Ulisses R Montarroyos; Wayner V de Souza; Patrícia Varejão; Laura C Rodrigues
Journal:  BMC Med Res Methodol       Date:  2007-02-23       Impact factor: 4.615

7.  VTE Risk assessment - a prognostic Model: BATER Cohort Study of young women.

Authors:  Lothar Aj Heinemann; Thai Dominh; Anita Assmann; Wolfgang Schramm; Rolf Schürmann; Jan Hilpert; Michael Spannagl
Journal:  Thromb J       Date:  2005-04-18

8.  Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases.

Authors:  Yana Vinogradova; Carol Coupland; Julia Hippisley-Cox
Journal:  BMJ       Date:  2015-05-26

9.  International Active Surveillance Study of Women Taking Oral Contraceptives (INAS-OC Study).

Authors:  Juergen C Dinger; Kristina Bardenheuer; Anita Assmann
Journal:  BMC Med Res Methodol       Date:  2009-11-18       Impact factor: 4.615

Review 10.  The Risk of Venous Thromboembolism with Different Generation of Oral Contraceptives; a Systematic Review and Meta-Analysis.

Authors:  Alireza Baratloo; Saeed Safari; Alaleh Rouhipour; Behrooz Hashemi; Farhad Rahmati; Maryam Motamedi; Mohammadmehdi Forouzanfar; Pauline Haroutunian
Journal:  Emerg (Tehran)       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.